115 related articles for article (PubMed ID: 6602185)
1. Critical aspects of immune complex assays employing polyethylene glycol.
Cooper KM; Moore M
J Immunol Methods; 1983 Jun; 60(3):289-303. PubMed ID: 6602185
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the soluble immune complexes that are detected by three different techniques.
van der Giessen M; The TH
Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
[TBL] [Abstract][Full Text] [Related]
3. Porcine C1q and the solid-phase immunoassay of human immune complexes.
Ziola B; Salmi A; Penttinen K
J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
6. Specific proteins precipitated by polyethylene glycol during assays for circulating C1q precipitable immune complexes.
Hyun J
Am J Clin Pathol; 1983 Nov; 80(5):777-8. PubMed ID: 6605678
[No Abstract] [Full Text] [Related]
7. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
9. [Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation)].
Coppo R; De Marchi M; Basolo B; Martina G; Rollino C; Boero R; Giraudo G; Rossano C; Quarello F; Piccoli G
Arch Sci Med (Torino); 1982; 139(4):381-92. PubMed ID: 6984818
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
[TBL] [Abstract][Full Text] [Related]
11. [Current situation and problems in the estimation of circulating immune complexes].
Yoshida H
Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
13. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
14. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
Jacobs RJ; Mocharla R
J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
[TBL] [Abstract][Full Text] [Related]
16. [Circulating immune complexes, detection in human glomerulonephritis by the PEG-EDTA technique (author's transl)].
Laurent B; Gonthier R; Genin C; Toulon J; Laurent P; Sabatier JC; Berthoux FC
Pathol Biol (Paris); 1982 Mar; 30(3):141-6. PubMed ID: 6808442
[TBL] [Abstract][Full Text] [Related]
17. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer.
Krieger G; Kneba M; Bolz I; Nagel GA
Clin Immunol Immunopathol; 1988 Jan; 46(1):14-23. PubMed ID: 3257175
[TBL] [Abstract][Full Text] [Related]
18. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
19. Types of immune complexes in the ascitic fluid of women with carcinoma of the ovary.
Silburn PA; Khoo SK; Daunter B; Hill R; Roberts TK; Mackay EV
Int Arch Allergy Appl Immunol; 1983; 71(3):219-23. PubMed ID: 6602096
[TBL] [Abstract][Full Text] [Related]
20. Rapid three-step purification procedure for isolation of the C1q component of human complement and its use in a solid-phase C1q binding assay.
Bähr EA; Drahovsky D
J Immunol Methods; 1984 Apr; 69(1):43-50. PubMed ID: 6325543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
